Apogee Therapeutics APGE Stock
Apogee Therapeutics Price Chart
Apogee Therapeutics APGE Financial and Trading Overview
| Apogee Therapeutics stock price | 135.07 USD |
| Previous Close | 0 USD |
| Open | 135.06 USD |
| Bid | 96.59 USD x 200 |
| Ask | 171.87 USD x 200 |
| Day's Range | 135.06 - 135.09 USD |
| 52 Week Range | 35.39 - 135.09 USD |
| Volume | 0 USD |
| Avg. Volume | 2.93M USD |
| Market Cap | 10.22B USD |
| Beta (5Y Monthly) | 0.327 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -4.34 USD |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 134.62 USD |
APGE Valuation Measures
| Enterprise Value | 9.22B USD |
| Trailing P/E | N/A |
| Forward P/E | -25.995647 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 8.487496 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -28.627 |
Trading Information
Apogee Therapeutics Stock Price History
| Beta (5Y Monthly) | 0.327 |
| 52-Week Change | 266.24% |
| S&P500 52-Week Change | 15.30% |
| 52 Week High | 135.09 USD |
| 52 Week Low | 35.39 USD |
| 50-Day Moving Average | 134.18 USD |
| 200-Day Moving Average | 93.12 USD |
APGE Share Statistics
| Avg. Volume (3 month) | 2.93M USD |
| Avg. Daily Volume (10-Days) | 1.43M USD |
| Shares Outstanding | 62.2M |
| Float | 58.44M |
| Short Ratio | 3.63 |
| % Held by Insiders | 2.31% |
| % Held by Institutions | 110.80% |
| Shares Short | 4.27M |
| Short % of Float | 7.28% |
| Short % of Shares Outstanding | 5.65% |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | NaN |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | June 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -20.29% |
| Return on Equity (ttm) | -32.45% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -322120000 USD |
| Net Income Avi to Common (ttm) | -294372992 USD |
| Diluted EPS (ttm) | -4.34 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 971.93M USD |
| Total Cash Per Share (mrq) | 12.89 USD |
| Total Debt (mrq) | 6.83M USD |
| Total Debt/Equity (mrq) | 0.57 USD |
| Current Ratio (mrq) | 26.439 |
| Book Value Per Share (mrq) | 15.914 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -243894000 USD |
| Levered Free Cash Flow (ttm) | -145624624 USD |
Profile of Apogee Therapeutics
| Country | United States |
| State | CA |
| City | San Francisco |
| Address | One Letterman Drive |
| ZIP | 94129-1492 |
| Phone | (650) 394-5230 |
| Website | https://www.apogeetherapeutics.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 261 |
Apogee Therapeutics, Inc. develops and commercializes biologic therapies for immunological and inflammatory (I&I) diseases for patients and caregivers. The company's pipeline includes products, such as ZUMILOKIBART (APG777), a monoclonal antibody for atopic dermatitis, asthma, and eosinophilic esophagitis; APG990, a monoclonal antibody targeting OX40L; APG808, an antibody targeting IL-4Ra for chronic obstructive pulmonary disease and asthma; APG333, a half-life extended TSLP antibody; APG279, a combination therapy for atopic dermatitis; and APG273 for asthma and COPD. It also provides services related to engineering and optimizing antibodies with improved pharmacokinetics to reduce injection frequency for patients. The company was founded in 2022 and is based in San Francisco, California with an additional office in Waltham, Massachusetts. As of September 3, 2026, Apogee Therapeutics, Inc. operates as a subsidiary of AbbVie Inc.
Q&A For Apogee Therapeutics Stock
What is a current APGE stock price?
Apogee Therapeutics APGE stock price today per share is 135.07 USD.
How to purchase Apogee Therapeutics stock?
You can buy APGE shares on the Tech Market Middle exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Apogee Therapeutics?
The stock symbol or ticker of Apogee Therapeutics is APGE.
Which industry does the Apogee Therapeutics company belong to?
The Apogee Therapeutics industry is Biotechnology.
How many shares does Apogee Therapeutics have in circulation?
The max supply of Apogee Therapeutics shares is 75.69M.
What is Apogee Therapeutics Price to Earnings Ratio (PE Ratio)?
Apogee Therapeutics PE Ratio is now.
What was Apogee Therapeutics earnings per share over the trailing 12 months (TTM)?
Apogee Therapeutics EPS is -4.34 USD over the trailing 12 months.
Which sector does the Apogee Therapeutics company belong to?
The Apogee Therapeutics sector is Healthcare.
Apogee Therapeutics APGE included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
|
|
{{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
US Tech Composite
IXIC
US
|
26333.04 USD — |
+0.96
|
5.66B USD — | 26283.11 USD — | 26431.22 USD — | — - | 5.66B USD — |
- {{ link.label }} {{link}}
